Nova Scotia’s lung screening program is making significant strides in early cancer detection, offering hope to individuals who may have otherwise faced a dire prognosis. Dr. Alison Wallace, a thoracic surgeon involved in the program, highlighted the positive impact seen so far, with more patients being referred at an early stage where the disease is potentially curable.
Lung cancer, often termed a silent killer due to its asymptomatic nature in the early stages, has a high fatality rate when diagnosed late. Nova Scotia’s screening initiative, which was initiated two years ago after persistent advocacy by Dr. Daria Manos, targets individuals aged 50 to 74 who have a history of daily smoking for at least 20 years.
The screening process involves nurses evaluating high-risk individuals for lung cancer and recommending CT scans for further assessment. To date, approximately 1,500 individuals have undergone these scans, leading to the identification of 55 cases of cancer or pending diagnoses. The program has notably detected more cases of early-stage, curable Stage 1 cancer, facilitating quicker surgical interventions and improved patient outcomes.
With plans for program expansion across Nova Scotia in the near future, efforts are underway to train additional healthcare professionals and enhance IT infrastructure for streamlined patient monitoring. While only half of participants receive scans, all are offered support for smoking cessation, underscoring the program’s holistic approach to improving lung health.
Collaboration with community organizations and ongoing monitoring of participants underscore the program’s commitment to early detection and intervention. By raising awareness and accessibility, the program aims to reach a broader demographic and ultimately reduce the burden of lung cancer in Nova Scotia.
